Healius Ltd
F:PGZ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Healius Ltd
F:PGZ
|
AU |
|
Kitron ASA
OSE:KIT
|
NO |
|
Fugro NV
F:F3DC
|
NL |
|
B
|
Buru Energy Ltd
F:BUD
|
AU |
|
C
|
Chorus Ltd
F:7CH
|
NZ |
|
Plazza AG
SIX:PLAN
|
CH |
|
L
|
Lloyds Banking Group PLC
F:LLD
|
UK |
|
T
|
Tyler Technologies Inc
F:TYP
|
US |
Intrinsic Value
Is PGZ undervalued or overvalued?
See the intrinsic value estimate for Healius Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
PGZ looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with PGZ’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Healius Does
Healius is an Australian medical diagnostics company. It mainly earns money by running pathology services, which means collecting patient samples and testing them in labs for doctors, hospitals, and other healthcare providers. It also has interests in related diagnostic services, so it sits behind the scenes as part of the healthcare testing process rather than as a hospital or doctor group.
- Headquarters
- Australia AU
- Employees
- 8 000
- IPO date
- Jul 3, 1998
Healius has no economic moat
Healius Ltd lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
Earnings Waterfall
Healius Ltd
The intrinsic value for Healius Ltd (PGZ) under the Base Case is hidden EUR.
Compared with the current market price of 0.26 EUR, the stock appears hidden.